北京时间2024年12月05日02时41分，Atai Life Sciences N.V.（ATAI.us）股票出现波动，股价急速跳水5.52%。截至发稿，该股报1.54美元/股，成交量73.256万股， 换手率 0.44%，振幅9.51%。

Rodman & Renshaw最近对Achieve Life Sciences给予"买入"评级，强调了该公司对这一全球健康危机的承诺。该公司还注意到公司正在探索cytisinicline的进一步适应症，包括用于电子烟和吸烟戒断。

ULT freezers are critical in life sciences, ensuring the stability and integrity of sensitive biological samples and reagents ...

Partnering with the Rhode Island Life Science Hub and Ancora L&G, Brown will provide leased space valued at $13 million over ...

北京时间2024年12月04日01时48分，Atai Life Sciences N.V.（ATAI.us）股票出现波动，股价急速下挫5.03%。截至发稿，该股报1.61美元/股，成交量68.9255万股， 换手率 0.41%，振幅4.14%。

Generative AI (Gen AI) has played an incredibly crucial role in this field. Innovators have developed a strong appetite for ...

Explore the intersection of science and marketing, showcasing the diverse career opportunities available in the life sciences ...

NEW YORK, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Questex's Fierce Biotech and Fierce Pharma today announces the winners of the ...

Blarcamesine的安全性数据显示无需常规核磁共振成像（MRI）对患者进行监测。新闻稿指出，其优势在于作为一种小分子口服药物，不仅对认知和神经退行性病变具有临床获益，而且因其简便的给药方式和良好的安全性而具有较大的吸引力。

鼻内给药foralumab目前正在进行一项2a期、随机、双盲、安慰剂对照、多中心、剂量范围试验。一项开放标签扩展获取计划报告称，在6个月内接受治疗的所有10名na-SPMS患者都出现了改善或稳定。FDA最近批准在该计划中增加20名患者。

Earlier this year, VanNurden led Fitzsimons and other organizations in a new campaign to recruit life sciences companies to ...

Facet Life Sciences, a leader in US regulatory strategy and product development solutions for the life sciences industry, has been named as the US regulatory partner for Cybin Inc. ("Cybin"), a ...